Last reviewed · How we verify

NCT05384405

aiTBS for Relieving NSSI in Depressive Patients

Recruiting now NA Last updated 1 May 2024
What this trial tests

NA trial testing Active iTBS in Major Depressive Disorder in 60 participants. Currently enrolling.

Timeline
1 July 2022
Primary endpoint
28 February 2025
28 February 2025

Quick facts

Lead sponsorCentral South University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date1 July 2022
Primary completion28 February 2025
Estimated completion28 February 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Central South University

Who can join

Adults 12 to 18, any sex, with Major Depressive Disorder or Bipolar Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries without suicidal ideation remained uncertain. This trial will compare the effectiveness of active accelerated intermittent theta burst stimulation (aiTBS) rTMS to a placebo control on non-suicidal self injury (NSSI) in patients with unipolar disorder and bipolar disorder.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Intermittent theta burst stimulation for non-suicidal self-injury in adolescents with major depressive disorder: a randomized, sham-controlled trial.
    Qin Y, Chen H, Liu F, Zou T, et al · · 2026 · cited 2× · PMID 40883451 · DOI 10.1038/s41380-025-03183-x

Verify or expand the search:

Other trials of Active iTBS

Trials testing the same drug.

Other recruiting trials for Major Depressive Disorder

Currently open trials in the same condition.

Other Central South University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05384405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing